Skip to main navigation
Skip to search
Skip to main content
Amsterdam UMC Home
Help & FAQ
Link opens in a new tab
Search content at Amsterdam UMC
Home
Researchers
Departments & Research Institutes
Projects & Funding
Publications
Datasets
Prizes
Activities
Courses
Cohorts
Press/Media
Impact
QT length during methadone maintenance treatment: gene × dose interaction
El-Hadi Zerdazi
, Florence Vorspan
, Andries T. Marees
, François Naccache
, Jean-Pierre Lepine
, Jean-Louis Laplanche
, Nathalie Prince
, Cynthia Marie-Claire
, Frank Bellivier
, Stéphane Mouly
, Vanessa Bloch
Doctoral School
ANS - Compulsivity, Impulsivity & Attention
APH - Mental Health
Affiliatie UvA
Research output
:
Contribution to journal
›
Article
›
Academic
›
peer-review
20
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'QT length during methadone maintenance treatment: gene × dose interaction'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Methadone
100%
Gene Dosage
100%
SNP
100%
Methadone Maintenance Treatment
100%
KCNE1
60%
Gene-based
40%
Risk Factors
20%
Clinically Significant
20%
QT Prolongation
20%
SCN5A
20%
KCNQ1
20%
KCNH2
20%
Sudden Death
20%
Genetic Factors
20%
Multiple Testing
20%
Pharmacological Treatment
20%
Remission
20%
Medical Conditions
20%
Minor Allele
20%
Heroin Dependence
20%
Genetic Background
20%
Enlargement
20%
Daily Dose
20%
Treatment Factors
20%
Corrected QT Interval
20%
Stratified Analysis
20%
Bazett's Formula
20%
NOS1AP
20%
Biochemistry, Genetics and Molecular Biology
Gene Dosage
100%
Methadone
100%
Single Nucleotide Polymorphism
62%
KCNE1
37%
Allele
25%
QTc Interval
12%
Electrocardiogram
12%
Genetic Background
12%
Heroin
12%
Drug-Induced QT Prolongation
12%
NOS1AP
12%
Immunology and Microbiology
Single Nucleotide Polymorphism
100%
Gene Dosage
100%
Allele
40%
Electrocardiogram
20%
Genetic Background
20%
QTc Interval
20%
Heroin
20%
Neuroscience
Methadone
100%
Gene Dosage
100%
Heroin
12%
Pharmacology, Toxicology and Pharmaceutical Science
Methadone
100%
Remission
12%
Diamorphine
12%
Sudden Death
12%
QT Prolongation
12%